Daiichi Sankyo Launches Amgen's Bevacizumab In Japan
Comes Shortly After Pfizer Debuted First Japanese Avastin Rival
Daiichi Sankyo has introduced Amgen’s bevacizumab biosimilar in Japan, hot on the heels of Pfizer’s launch of its own rival to Avastin in the country.
